DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes

被引:274
作者
Costanzo, A
Merlo, P
Pediconi, N
Fulco, M
Sartorelli, V
Cole, PA
Fontemaggi, G
Fanciulli, M
Schiltz, L
Blandino, G
Balsano, C
Levrero, M
机构
[1] Univ Roma La Sapienza, Fdn Andrea Cesalpino, Gene Express Lab, I-00161 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Dermatol, I-00161 Rome, Italy
[3] NIAMS, Muscle Biol Lab, Muscle Gene Express Grp, NIH, Bethesda, MD 20892 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[5] Regina Elena Canc Ctr, Dept Expt Oncol, I-00158 Rome, Italy
[6] Univ Aquila, Dept Internal Med, I-67100 Laquila, Italy
[7] Univ Cagliari, Dept Internal Med, I-09124 Cagliari, Italy
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S1097-2765(02)00431-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor p53 and its close relative p73 are activated in response to DNA damage resulting in either cell cycle arrest or apoptosis. Here, we show that DNA damage induces the acetylation of p73 by the acetyltransferase p300. Inhibiting the enzymatic activity of p300 hampers apoptosis in a p53(-/-) background. Furthermore, a nonacetylatable p73 is defective in activating transcription of the proapoptotic p53AIP1 gene but retains an intact ability to regulate other targets such as p21. Finally, p300-mediated acetylation of p73 requires the protooncogene c-abl. Our results suggest that DNA damage-induced acetylation potentiates the apoptotic function of p73 by enhancing the ability of p73 to selectively activate the transcription of proapoptotic target genes.
引用
收藏
页码:175 / 186
页数:12
相关论文
共 39 条
  • [1] Agami R, 1999, NATURE, V399, P809
  • [2] Attardi LD, 2000, GENE DEV, V14, P704
  • [3] Recruitment of p300/CBP in p53-dependent signal pathways
    Avantaggiati, ML
    Ogryzko, V
    Gardner, K
    Giordano, A
    Levine, AS
    Kelly, K
    [J]. CELL, 1997, 89 (07) : 1175 - 1184
  • [4] BOYER JC, 1995, CANCER RES, V55, P6063
  • [5] Regulation of activity of the transcription factor GATA-1 by acetylation
    Boyes, J
    Byfield, P
    Nakatani, Y
    Ogryzko, V
    [J]. NATURE, 1998, 396 (6711) : 594 - 598
  • [6] ELDEIRY WS, 1994, CANCER RES, V54, P1169
  • [7] Friedlander P, 1996, MOL CELL BIOL, V16, P4961
  • [8] Mutations truncating the EP300 acetylase in human cancers
    Gayther, SA
    Batley, SJ
    Linger, L
    Bannister, A
    Thorpe, K
    Chin, SF
    Daigo, Y
    Russell, P
    Wilson, A
    Sowter, HM
    Delhanty, JDA
    Ponder, BAJ
    Kouzarides, T
    Caldas, C
    [J]. NATURE GENETICS, 2000, 24 (03) : 300 - 303
  • [9] The complexity of p53 modulation: emerging patterns from divergent signals
    Giaccia, AJ
    Kastan, MB
    [J]. GENES & DEVELOPMENT, 1998, 12 (19) : 2973 - 2983
  • [10] Gong JG, 1999, NATURE, V399, P806